Tranilast structure
Tranilast
Tranilast is an antiallergic agent.Target: Angiotensin ReceptorTranilast has been approved in Japan and South Korea, since 1982, for the treatment of bronchial asthma, with indications for keloids and hypertrophic scar added in 1993. Tranilast is also used to treat asthma, autoimmune diseases, atopic and fibrotic pathologies, and can also inhibit angiogenesis. The antiproliferative properties of tranilast were found that tranilast elicited an inhibitory effect on fibroblast proliferation
Find 2 Related Holders
China Pharmaceutical University Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
1994-12-05 -
Country:
China -
Address:
No. 50, Majia Street, Gulou District, Nanjing -
Tax NO.:
91320000134755425F -
Registered Funds:
98 million yuan -
Website:
-
Email:
Nanjing Yiheng Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
2003-07-11 -
Country:
China -
Address:
No. 118, Huabao Road, Jiangbei New District, Nanjing -
Tax NO.:
91320111751298514H -
Registered Funds:
50 million yuan -
Website:
-
Email:
Recommended Suppliers of Tranilast
-
Hainan Flying International Trade Co., L
CN1 YR
Contact Supplier -
Amitychem
CN1 YR
Contact Supplier -
Guangzhou Yaoguang Technology Co., Ltd.
CN1 YR
Contact Supplier -
Hangzhou Raisun Import & Export Co Ltd
CN1 YR
Contact Supplier -
GIHI CHEMICALS CO.,LIMITED
CN1 YR
Contact Supplier